Clinical ResearchEnhanced Mortality Risk Prediction With a Focus on High-Risk Percutaneous Coronary Intervention: Results From 1,208,137 Procedures in the NCDR (National Cardiovascular Data Registry)
Key Words
Abbreviations and Acronyms
Cited by (0)
This research was supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR). The views expressed in this manuscript represent those of the author(s), and do not necessarily represent the official views of the NCDR or its associated professional societies identified at www.ncdr.com. Dr. Curtis has received salary support from the American College of Cardiology and Centers for Medicare & Medicaid Services; he also owns stock in Medtronic. Dr. Khandelwal has received consulting fees from Terumo Medical Corp. Dr. Spertus has received consulting fees from the American College of Cardiology Foundation for the analysis of NCDR data. Dr. Weaver has served on the Data and Safety Monitoring Board of Boston Scientific. Dr. Peterson has received consulting fees from Janssen Pharmaceuticals, Boehringer Ingelheim, Pfizer, and Eli Lilly. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.